Trials / Completed
CompletedNCT06427434
Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Postnatal Low Back Pain
Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Low Back Pain in Postnatal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study will be carried out to evaluate the effect of modified lumbar Sustained Natural Apophyseal Glide on low back pain in postnatal women.
Detailed description
In fact, up to 75% of women who suffer from pregnancy-related back pain may continue to have pain after giving birth. Women who experience LBP or pelvic girdle pain (PGP) at 3 months postpartum were found to be at higher risk for persistent or chronic LBP. Of these women, only 6% recover within 6-18 months after giving birth. A modified lumbar Sustained Natural Apophyseal Glide (SNAG) is an existing Mulligan mobilization technique performed with a combination of joint glide and physiological spinal movement. The glide can be applied to the spinous processes, facets, or unilaterally over the transverse processes while the patient performs the active exercise. Few studies have been concerned with the effects of modified "SNAGS" on the lumbar spine . So, this study will be done to investigate its effect on low back pain in postnatal women aiming to improve their function to accomplish their daily living activities and reduce the side effects of medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Strengthening and stretching exercises to the back and abdominal muscles | Strengthening and stretching exercises to the back and abdominal muscles will be performed for 30 min, three times per week for 4 weeks. |
| OTHER | Modified Lumbar Sustained Natural Apophyseal Glide | Modified Sustained Natural Apophyseal Glide will be applied on the affected lumbar level for 30 sec three times per week for 4 weeks. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2024-12-15
- Completion
- 2024-12-30
- First posted
- 2024-05-23
- Last updated
- 2025-05-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06427434. Inclusion in this directory is not an endorsement.